๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metachromatic leukodystrophy: Identification of the first deletion in exon 1 and nine novel point mutations in the arylsulfatase A gene

โœ Scribed by Ruxandra Draghia; Franck Letourneur; Cristina Drugan; Jeanne Manicom; Christophe Blanchot; Axel Kahn; Livia Poenaru; Catherine Caillaud


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
273 KB
Volume
9
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Metachromatic leukodystrophy (MLD), a lysosomal storage disease caused by the deficiency of arylsulfatase A (ASA), is inherited as an autosomal recessive trait, and its frequency is estimated to be 1 in 40,000 live births. Genomic DNA from 21 MLD patients (14 late-infantile and 7 juvenile cases) was amplified in four overlapping PCR fragments and tested by allele-specific oligonucleotide (ASO) for the two common mutations 459 + lGรƒA and P426L. These mutations were found in only 28.6% of the alleles studied. The remaining alleles were analyzed by chemical mismatch cleavage (CMC and automatic sequencing. In addition to five previously reported mutations (459 + lGรƒA, A212V, R244C, R390W, P426L), 10 novel mutations were identified: 9 missense mutations (S95N, G119R, D152Y, R244H, S250Y, A314T, R384C, R496H, K367N) and one 8 bp deletion in exon 1, the first mutation reported in this exon. These methods allowed us to identify 76% of the alleles tested. Genotype-phenotype correlations could be established for some of these mutations. These results confirm the heterogeneity of mutations causing MLD and suggest that CMC is a reliable and informative screening method for point mutation detection in the arylsulfatase A gene. Hum


๐Ÿ“œ SIMILAR VOLUMES


Identification of 12 novel mutations and
โœ Laura Gort; M. Josep Coll; Amparo Chabรกs ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 305 KB ๐Ÿ‘ 1 views

Arylsulfatase A (ARSA) deficiency is the main cause of metachromatic leukodystrophy (MLD), a lysosomal disorder with no specific treatment. In view of the importance of genetic counseling, analyses of mutations and polymorphisms, including the ARSA pseudodeficiency allele, were carried out in 18 unr

Identification of a cell type-specific s
โœ Fan Xu; Alice J. Paquette; David J. Anderson; Andreas Charalambous; David S. Ask ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 180 KB ๐Ÿ‘ 1 views

The His-1 gene is developmentally expressed in the murine choroid plexus but is silenced in the adult brain. To test the hypothesis that the gene contains cis-acting elements that contribute to this repression, we have analyzed segments of the proximal promoter for negative regulatory sequences by t

Identification of a new heterozygous poi
โœ Sergej Feshchenko; Jรผrgen Brinckmann; Hartwig W. Lehmann; Hans-Georg Koch; Peter ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB ๐Ÿ‘ 2 views

A heterozygous deletion of exon 9 in the COL1A2 -mRNA of a patient with symptoms of both the Ehlers -Danlos -Syndrome and the Osteogenesis Imperfecta is described. In the genomic DNA of the patient, exon 9 is homozygously present. We identified a novel heterozygous point mutation in the splice donor